VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2025 Earnings Call Transcript
Q3 2025 Earnings Call Transcript February 13, 2025 Operator: And good day. Thank you for standing by. Welcome to VistaGen ...
StockNews.com Begins Coverage on Cellectar Biosciences (NASDAQ:CLRB)
Investment analysts at StockNews.com initiated coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a report issued on Friday. The brokerage set a “sell” rating on the ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Sold by Yousif Capital Management LLC
Yousif Capital Management LLC reduced its position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 5.2% in the 4th quarter, according to the company in its most recent 13F filing ...
The Spanish researcher behind the great hope against cancer announces the surprise: “Keep this date”
Asier Unciti-Broceta and his team have several different research programs underway, with one drug offering hope a cure for ...
UroToday16h
ASCO GU 2025: EPIC-B: Phase II Trial of Cemiplimab as First-Line Treatment in Advanced Penile Carcinoma
The EPIC-B trial demonstrates the efficacy of cemiplimab monotherapy as a treatment for locally advanced or metastatic penile cancer (la/mPC). The trial met its primary endpoint, with a clinical ...